CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $62,000 | +47.6% | 26,749 | +79.1% | 0.00% | – |
| Q4 2017 | $42,000 | -64.1% | 14,935 | -63.5% | 0.00% | -100.0% |
| Q3 2017 | $117,000 | +74.6% | 40,906 | +50.6% | 0.00% | 0.0% |
| Q2 2017 | $67,000 | -19.3% | 27,160 | +18.4% | 0.00% | 0.0% |
| Q1 2017 | $83,000 | -64.5% | 22,939 | -65.3% | 0.00% | -50.0% |
| Q4 2016 | $234,000 | +88.7% | 66,198 | +101.2% | 0.00% | +100.0% |
| Q1 2016 | $124,000 | -41.8% | 32,904 | +62.7% | 0.00% | 0.0% |
| Q3 2015 | $213,000 | -72.6% | 20,221 | -34.3% | 0.00% | -80.0% |
| Q2 2015 | $776,000 | +57.7% | 30,761 | +74.2% | 0.01% | +66.7% |
| Q1 2015 | $492,000 | +25.8% | 17,656 | -17.5% | 0.00% | +50.0% |
| Q4 2014 | $391,000 | -23.5% | 21,406 | -26.0% | 0.00% | 0.0% |
| Q1 2014 | $511,000 | +221.4% | 28,937 | +341.6% | 0.00% | +100.0% |
| Q4 2013 | $159,000 | -73.2% | 6,553 | -60.9% | 0.00% | -50.0% |
| Q3 2013 | $594,000 | – | 16,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |